Early experience with teprotumumab for chronic thyroid eye disease
Author:
Funder
Kathleen and Steve Flynn
Bell Charitable Foundation
Research to Prevent Blindness
Publisher
Elsevier BV
Subject
Ophthalmology
Reference12 articles.
1. Clinical features of Graves' ophthalmopathy in an incidence cohort;Bartley;Am J Ophthalmol,1996
2. Psychological disturbance in graves ophthalmopathy;Farid;Arch Ophthalmol,2005
3. Rundle and his curve;Bartley;Arch Ophthalmol,2011
4. Efficacy and safety of immunosuppressive agents for thyroid eye disease;Strianese;Ophthalmic Plast Reconstr Surg,2018
5. Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy;Bartalena;J Clin Endocrinol Metab,2012
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Teprotumumab for the Treatment of Thyroid Eye Disease;Endocrine Reviews;2024-06-05
2. Effects of Teprotumumab on Eyelid Retraction in Thyroid Eye Disease;Ophthalmic Plastic & Reconstructive Surgery;2024-05-09
3. Side Effects and Adverse Events After Treatment With Teprotumumab for Thyroid Eye Disease: A Retrospective Observational Case Series;Cureus;2024-04-19
4. Teprotumumab for Thyroid Eye Disease-related Strabismus;Ophthalmic Plastic & Reconstructive Surgery;2024-02-02
5. A comparison of proptosis reduction with teprotumumab versus surgical decompression based on fat-to-muscle ratio in thyroid eye disease;Orbit;2023-11-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3